DCN Dx

  • BioTech/Drugs
  • Carlsbad CA
  • 75 employees
  • Biotechnology
Get Full Info

Company Overview

Headquarters
3193 Lionshead Ave Suite 200, Carlsbad CA
Website
dcndx.com
Phone
(760) 804-3886
Employees
75
Founded in
2005
Industry
BioTech/Drugs
NAICS Code
NAICS Code 54 Companies
NAICS Code 6215 Companies
NAICS Code 62151 Companies
NAICS Code 62 Companies
NAICS Code 621 Companies
NAICS Code 541 Companies
SIC Code
SIC Code 807 Companies
SIC Code 80 Companies
SIC Code 8071 Companies
More Details

Financials & Stats

Revenue

$9B

Total Funding Amount

$350,000M

More Financials

Who is DCN Dx

DCN Dx is a privately held company located in Carlsbad, California. With 75 employees, the company generates $8.5 million in annual revenue. DCN Dx specializes in the contract development of rapid point-of-care tests. The company offers a range of services and products designed to assist clients in developing user-centric, high-performing diagnostic devices. Their core expertise lies in contract development of rapid immunoassays, encompassing lateral flow, flow-through, and microfluidic formats. DCN Dx boasts a team with extensive experience in developing assays that meet stringent specifications regarding sensitivity, quantification, multiplexing, and reader integration. DCN Dx's integrated engineering team designs, develops, and integrates complete devices, ensuring seamless integration of assay and device development pathways. Beyond assay development, they provide a variety of supplementary products and services, including customized training courses in lateral flow technology, consulting services covering various aspects of rapid assay development, manufacturing, regulation, and commercialization, and customized conjugations. DCN Dx can be contacted via their website at www.dcndx.com, by email at [email protected], or by phone at (760) 804-3886.

Company Leadership

Michael Surmanian

Co-Founder

Phone Email
Angela Rapattoni

VP of Finance

Phone Email
Patrick Coffey

Vice President of Engineering

Phone Email
Mitzi Rettinger

Chief Revenue Officer (CRO)

Phone Email

DCN Dx Industry Tags

Development of lateral flow immunoassays
Quantitative
reader based lateral flow assay development
Education and Training in Lateral Flow Technology
Custom protein
particle and small molecule conjugation
Consulting services
Manufacturing transfer services
Lateral Flow Education and Training
Manufacturing Transfer and Support
Rapid Test Development
Strategic and Technical Consulting
Industrial Design and Engineering
Quantification
Multiplexing & Arraying in Lateral Flow Format
Fluorescent or Visual Labels
Lateral Flow
Point of Care
Diagnostics
Lateral Flow Readers
Conjugation Kits
Colloidal Gold
Cellulose Nanobeads
Nanoparticles
BioTech/Drugs
Commercial Physical Research
Biotechnology
Biotech Pharmaceuticals
View All Industry Tags

Companies Similar to DCN Dx

Analyze industry trends and opportunities by examining competitors and companies comparable to DCN Dx, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
9M 23 Birmingham, AL 1982
9M 4 Carlsbad, CA 2006
9M 212 Plymouth Meeting, PA 2012
9M 35 Gaithersburg, MD 2016
9M 34 Saint Paul, MN 2014
View More Companies

FAQ

What is the location of DCN Dx's headquarters?
The headquarters of DCN Dx are situated at 3193 Lionshead Ave Suite 200, Carlsbad CA
What is DCN Dx's phone number?
DCN Dx's contact number is (760) 804-3886.
What is DCN Dx's official website?
The official website of DCN Dx can be found at dcndx.com.
What is DCN Dx's current revenue?
As of April 2022, DCN Dx's annual revenue reached $9B.
How many employees does DCN Dx currently have?
DCN Dx employs approximately 75+ people as of April 2022
Which industries is DCN Dx primarily operating in?
DCN Dx operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the Co-Founder of DCN Dx?
DCN Dx's Co-Founder is Michael Surmanian
What are DCN Dx's industry tags?
DCN Dx's industry tags include: Development of lateral flow immunoassays, Quantitative, reader based lateral flow assay development
What is DCN Dx's total funding to date?
DCN Dx has secured $350,000M as of April 2022
When was DCN Dx founded?
DCN Dx was founded in 2005.

Employee Directory

Key Employees

Charlie Mamrak

CEO

Phone Email

Bret Sheffield

Program Manager

Phone Email

shekufe Maher

Laboratory Technician

Phone Email

Jacqueline Olson

Marketing and Sales

Phone Email

Francis Ko

Vice President, Manufacturing Operations

Phone Email

Megan Slama

Manufacturing and Technical Support Specialist II

Phone Email